Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40

Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
Health Carousel Taps into AI

Health Carousel Taps into AI

Health Carousel, a healthcare staffing firm with over 1,000 workers under contract, has acquired the digital health platform Lucidity. The target’s technology platform connects physicians seeking part-time or temporary work directly with medical practices looking to fill open shifts, while also using artificial intelligence (AI) technology to help providers and medical practices make better staffing decisions. Lucidity had previously raised funding from Sustineo Ventures. Financial terms were not disclosed. Lucidity will continue to operate as a standalone company under its own brand after the transaction. The business will join the Health Carousel Locums Network (HCLN) as part of... Read More »
Health Care M&A Deals, Week Ending May 17, 2019

Health Care M&A Deals, Week Ending May 17, 2019

The Health Care M&A Weekly chart is a selection of transactions announced during the prior week(s). The deals presented here are from our Deal Search Online database, which is updated every business day. Visit www.dealsearchonline.com to see how Deal Search Online can help you stay up-to-date on the healthcare market overall, or in a particular sector of interest to your firm. Behavioral Health Care     Acquirer Target Price Swanton Care & Community Values in Care Ltd and GRS Care Ltd N/A Kadiant Central Valley Autism Project N/A eHealth     Acquirer Target Price Health Carousel Lucidity N/A MiraMed Global Services LLC Medac, Inc N/A Discovery Health Partners... Read More »
Autism Therapy Provider Hopebridge Changes Hands Again

Autism Therapy Provider Hopebridge Changes Hands Again

Autism treatment companies are still hot targets in 2019. Eight transactions have been announced so far this year, compared with 20 in all of 2018. (That was an outsized year for every healthcare sector. There were nine deals for autism targets in 2017.) Private equity firms are trading platforms in this sub-sector. Just this year, Gryphon Investors bought Learn Behavioral from LLR Partners for an undisclosed amount. Now there’s the deal between Baird Capital and Arsenal Capital Partners for Hopebridge LLC. Hopebridge LLC was launched in 2005 in Indianapolis, Indiana to serve the growing need for autism treatment services. The clinic-based autism therapy business provides Applied... Read More »
Oak Hill Capital Exits AccentCare

Oak Hill Capital Exits AccentCare

May has been a busy month for deals in the Home Health & Hospice sector with eight transactions announced midway through the month. The latest is Oak Hill Capital Partners’ sale of its post-acute care platform, AccentCare, Inc. to Advent International. Financial terms were not disclosed. Today, AccentCare is the sixth largest home health platform and the third largest personal care platform in the United States. It serves health systems, physician practices and managed care organizations, and includes strategic joint ventures and partnerships. Its range of services includes personal, non-medical care to skilled nursing, rehabilitation, hospice care and care management. Oak Hill... Read More »
Health Care M&A Deals, Week Ending May 17, 2019

Health Care M&A Deals, Week Ending May 10, 2019

The Health Care M&A Weekly chart is a selection of transactions announced during the prior week(s). The deals presented here are from our Deal Search Online database, which is updated every business day. Visit www.dealsearchonline.com to see how Deal Search Online can help you stay up-to-date on the healthcare market overall, or in a particular sector of interest to your firm. Behavioral Health Care     Acquirer Target Price Perimeter Healthcare 2 Sundance pyschiatric hospitals N/A Arsenal Capital Partners Hopebridge LLC N/A Biotechnology     Acquirer Target Price Pfizer Inc. Therachon Holding AG $340,000,000 eHealth     Acquirer Target Price Harris... Read More »
Xiidra, Dry Eye Treatment Drug, Acquired by Novartis

Xiidra, Dry Eye Treatment Drug, Acquired by Novartis

The global pharmaceutical giant Novartis (NYSE: NVS) bought the assets to Xiidra 5% solution from Takeda Pharmaceutical Company (NYSE: TAK). The announcement gives us the largest pharmaceutical deal of the year so far, with Novartis paying $3.4 billion upfront and $1.9 billion in potential milestones for the drug. In 2018, Xiidra generated revenue of $400 million. Xiidra is the first and only prescription treatment approved for both signs and symptoms of dry eye by inhibiting inflammation caused by the disease. This acquisition fits strategically within Novartis’ ophthalmic pharmaceutical portfolio, laying the groundwork for front-of-the-eye pipeline products currently in... Read More »
April Healthcare Deal Volume Nudges Higher

April Healthcare Deal Volume Nudges Higher

Everyone we’ve talked to in recent weeks agrees that the first quarter of 2019 was very slow, even slower than expected. So a slight uptick (+5%) in April’s deal volume was a welcome sign of Spring. May’s early activity is even stronger than April’s. but we know how quickly that can change. One example: President Trump returned to threatening more and higher tariffs on imported goods from China as trade talks appeared to bog down in the first week of May. The markets held up for a day, then sentiment turned pessimistic and we’re back to the uncertainty that prevailed at the end of 2018. And we know how much investors like uncertainty. April 2019’s deal volume (132 deals) had a hard comp... Read More »
Telehealth: Answering the Call

Telehealth: Answering the Call

If you’ve attended any healthcare deal-making conference in the last few years, you’ve heard that telehealth is one of the hottest target sectors going, right up there with autism services and physician practices (dermatologists, ophthalmologists, dentists, you name it). It’s caught in something of a perfect storm at the moment, as more states and regions implement laws to facilitate telehealth services. On the federal level, the Centers for Medicare and Medicaid Services on April 5, 2019 finalized policies that increase plan choices and benefits, including allowing Medicare Advantage plans to include additional telehealth benefits. Private health insurers have been offering telehealth... Read More »
BayMark Health Keeps Buying

BayMark Health Keeps Buying

BayMark Health Services, a portfolio company of Webster Equity Partners (formerly known as Webster Capital), is still on the acquisition trail, even as it is reportedly prepping for a sales process. In its first deal announced in 2019, BayMark targeted Recovery Services of New Mexico, based in Albuquerque. Recovery Services offers opioid treatment programs for patients around the state. It has three traditional opioid treatment programs, one office-based treatment program and a fifth location inside of Bernalillo County Metropolitan Detention Center. BayMark provides medication-assisted treatment for opiate addiction and dependency to thousands of patients nationwide. It is the largest... Read More »
Health Care M&A Deals, Week Ending May 17, 2019

Health Care M&A Deals, Week Ending May 3, 2019

The Health Care M&A Weekly chart is a selection of transactions announced during the prior week(s). The deals presented here are from our Deal Search Online database, which is updated every business day. Visit www.dealsearchonline.com to see how Deal Search Online can help you stay up-to-date on the healthcare market overall, or in a particular sector of interest to your firm. Behavioral Health Care     Acquirer Target Price Pinnacle Treatment Centers Addiction Medicine Care of Columbus N/A Biotechnology     Acquirer Target Price Canopy Biosciences, LLC Zellkraftwerk GmbH N/A eHealth     Acquirer Target Price Capsule Technologies, Inc Bernoulli Health N/A... Read More »